title: Danazol treatment and follow-up of patients with endometriosis.
abstract: In conclusion, we find that danazol has proved to be highly effective as a treatment for endometriosis. On the dosage used, we have not achieved the freedom from side-effects which we had hoped for, but in general these have been much less severe than those with combined oestrogen progestogen preparations. We propose continuing the trial with a reduced dosage of 400 mg daily in the hope of further reducing the incidence of side-effects.
mesh_terms: D003613:Danazol / Q000008:administration & dosage / Q000627:therapeutic use*; D004715:Endometriosis / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D010386:Pelvic Neoplasms / Q000188:drug therapy*; D011245:Pregnadienes / Q000627:therapeutic use*; D011247:Pregnancy
chemical_list: D011245:Pregnadienes; D003613:Danazol